Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
Titel:
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
Auteur:
Kremsner, Peter G Ahuad Guerrero, Rodolfo Andrés Arana-Arri, Eunate Aroca Martinez, Gustavo Jose Bonten, Marc Chandler, Reynaldo Corral, Gonzalo De Block, Eddie Jan Louis Ecker, Lucie Gabor, Julian Justin Garcia Lopez, Carlos Alberto Gonzales, Lucy Granados González, María Angélica Gorini, Nestor Grobusch, Martin P Hrabar, Adrian D Junker, Helga Kimura, Alan Lanata, Claudio F Lehmann, Clara Leroux-Roels, Isabel Mann, Philipp Martinez-Reséndez, Michel Fernando Ochoa, Theresa J Poy, Carlos Alberto Reyes Fentanes, Maria Jose Rivera Mejia, Luis Maria Ruiz Herrera, Vida Veronica Sáez-Llorens, Xavier Schönborn-Kellenberger, Oliver Schunk, Mirjam Sierra Garcia, Alexandra Vergara, Itziar Verstraeten, Thomas Vico, Marisa Oostvogels, Lidia